Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients.

To study the effects of HIV-infection and protease inhibitor -based highly active anti-retroviral therapy on the lipid and high-density lipoprotein subpopulation profile and to relate the changes to coronary heart disease -risk.

http://ift.tt/1jsJTSf